Erratum to “Retinitis Pigmentosa GTPase regulator–Associated Retinal Degeneration: Integrating Patient-Reported Outcomes, Genetic, and Structural Biomarkers” [Ophthalmology Science 6 (2026) 100915]
Nuno Gouveia, MD, MSc,1,2,3 Jessica S. Karuntu, MD,4 Hind Almushattat, MD,5 Rufino Silva, MD, PhD,1,2,3 Camiel J.F. Boon, MD, PhD,4,5 João Pedro Marques, MD, PhD1,2,3
1 Ophthalmology Department, Hospitais da Universidade de Coimbra (HUC), Unidade Local de Saúde de Coimbra (ULS-C), Coimbra, Portugal.
2 Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.
3 Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.
4 Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
5 Department of Ophthalmology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Correspondence: João Pedro Marques, MD, PhD, Department of Ophthalmology, Hospitais da Universidade de Coimbra, ULS de Coimbra, Praceta Prof. Mota Pinto, Coimbra 3004-561, Portugal. E-mail: marquesjoaopedro@gmail.com.
The publisher of this journal would like to note an error in the article “Retinitis Pigmentosa GTPase Regulator–Associated Retinal Degeneration: Integrating Patient-Reported Outcomes, Genetic, and Structural Biomarkers.” During typesetting, errors were introduced to Table 2, resulting in some of the columns displaying incomplete information. The corrected Table 2 is provided here.
Table 2.
Cohort’s Genetic Landscape
| Genetic Variant (Total 22) | Location | Molecular Consequence | ACMG Classification | No. of Families (Total 24) | No. of Patients (Total 51) | Country of Origin |
|---|---|---|---|---|---|---|
| c.1243_1244del p.(Arg415Glyfs∗37) | Exon 10 | Frameshift | Pathogenic | 3 | 12 | Portugal |
| c.2872del p.(Glu958Lysfs∗131) | ORF 15 | Frameshift | Likely pathogenic | 1 | 7 | Portugal |
| c.2763_2764del p.(Glu922Glyfs∗156) | ORF 15 | Frameshift | Pathogenic | 1 | 6 | Portugal |
| c.2615_2616del p.(Glu872Glyfs∗206) | ORF 15 | Frameshift | Likely pathogenic | 1 | 5 | Portugal |
| c.2501del p.(Glu834Glyfs∗255) | ORF 15 | Frameshift | Pathogenic | 1 | 2 | Portugal |
| c.3040del p.(Glu1014Argfs∗75) | ORF 15 | Frameshift | Pathogenic | 1 | 2 | Portugal |
| c.778+5G>A p.? | Exon 7 | Intron variant/splice region | VUS | 1 | 2 | Portugal |
| c.1241_1245dup p.(Glu416Argfs∗11) | Exon 10 | NA | Likely pathogenic | 1 | 1 | The Netherlands |
| c.1261dup p.(Ser421Phefs32) | Exon 11 | Frameshift | Likely pathogenic | 1 | 1 | Portugal |
| c.1561C>T p.(Gln521∗) | Exon 13 | Stop gain | Pathogenic | 1 | 1 | The Netherlands |
| c.169T>G p.(Tyr57Asp) | Exon 3 | Missense | VUS | 1 | 1 | Portugal |
| c.1773_1776del p.(Gly592Glufs∗9) | ORF 15 | Frameshift | Pathogenic | 1 | 1 | The Netherlands |
| c.2997_2998del p.(Glu1000Glyfs∗78) | ORF 15 | Frameshift | Pathogenic | 1 | 1 | Portugal |
| c.2379del p.(Gly794Glufs∗21) | ORF 15 | Frameshift | VUS | 1 | 1 | Portugal |
| c.2426_2427del p.(Glu809Glyfs∗25) | ORF 15 | Frameshift | Pathogenic | 1 | 1 | Portugal |
| c.2064delG p.(Arg688Ser∗fs9) | ORF 15 | Frameshift | VUS | 1 | 1 | Portugal |
| c.2236_2237del p.(Glu746Argfs∗23) | ORF 15 | Frameshift | Likely pathogenic | 1 | 1 | The Netherlands |
| c.2346delG p.(Lys783fs) | ORF 15 | Frameshift | Pathogenic | 1 | 1 | The Netherlands |
| c.469+1G>T p.? | Exon 5 | Splice donor | Pathogenic | 1 | 1 | The Netherlands |
| c.425T>G p.(Ile142Ser) | Exon 5 | Missense | Pathogenic | 1 | 1 | The Netherlands |
| c.3013_3014del p.(Gly1005Argfs∗73) | ORF 15 | Frameshift | Pathogenic | 1 | 1 | The Netherlands |
| c.27del p.(Asp10Ilefs∗58) | Exon 1 | Frameshift | Likely pathogenic | 1 | 1 | The Netherlands |
ACMG = American College of Medical Genetics; NA = not applicable; ORF = open reading frame; VUS = variant of uncertain significance.
DOI of original article: 10.1016/j.xops.2025.100915
